1,314
Views
12
CrossRef citations to date
0
Altmetric
Commentary

Breaking the cycle of opioid use disorder with Ibogaine

, PhD
 

Declaration of interest and financial disclosures

The author is an inventor on issued patents pertaining to the active metabolite of ibogaine. She is a founder and shareholder in a Florida corporation, DemeRx, Inc., which is advancing clinical trials of noribogaine for opioid detoxification and maintenance therapy, among other indications. The author conducted offshore ibogaine research studies with government approval in St. Kitts, West Indies.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.